anmelden
Novartis Aktie
128,14
EUR
-0,16
EUR
-0,12
%
128,16
EUR
-0,82
EUR
-0,64
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Novartis Aktie Analyse
| 19.04.05 | Novartis Buy | Merrill Lynch | |
| 19.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 18.04.05 | Novartis Outperform | Goldman Sachs | |
| 18.04.05 | Novartis Neutral | JP Morgan | |
| 15.04.05 | Novartis Kaufen | Helaba Trust | |
| 15.04.05 | Novartis Neutral | Sarasin Research | |
| 15.04.05 | Novartis Neutral | HypoVereinsbank | |
| 14.04.05 | Novartis Reduce | UBS | |
|
Werbung
|
|||
| 14.04.05 | Novartis Reduce | UBS | |
| 14.04.05 | Novartis Underperform | Credit Suisse First Boston | |
| 13.04.05 | Novartis Neutral | Sarasin Research | |
| 08.04.05 | Novartis Accumulate | Helvea | |
| 21.03.05 | Novartis Accumulate | Helvea | |
| 21.03.05 | Novartis Kaufen | Helaba Trust | |
| 21.03.05 | Novartis Neutral | Sarasin Research | |
| 18.03.05 | Novartis Neutral | Sarasin Research | |
| 16.03.05 | Novartis Outperform | Goldman Sachs | |
| 11.03.05 | Novartis Neutral | Sarasin Research | |
| 11.03.05 | Novartis Buy | Helvea | |
| 10.03.05 | Novartis Neutral | Sarasin Research | |
| 09.03.05 | Novartis Buy | Merrill Lynch | |
| 07.03.05 | Novartis Neutral | Sarasin Research | |
| 24.02.05 | Novartis Overweight | Lehman Brothers | |
| 22.02.05 | Novartis Buy | Helvea | |
| 22.02.05 | Novartis Outperform | Goldman Sachs | |
| 21.02.05 | Novartis Kaufen | Helaba Trust | |
| 21.02.05 | Novartis Hold | SEB | |
| 21.02.05 | Novartis Akkumulieren | Independent Research | |
| 21.02.05 | Novartis Buy | Helvea | |
| 21.02.05 | Novartis Neutral | Sarasin Research | |
| 09.02.05 | Novartis Buy | Merrill Lynch | |
| 02.02.05 | Novartis Übergewichten | Reuschel & Co | |
| 01.02.05 | Novartis Kaufen | SYZ & CO | |
| 31.01.05 | Novartis Outperform | Credit Suisse First Boston | |
| 28.01.05 | Novartis Buy | Helvea | |
| 27.01.05 | Novartis Outperformer | Sparkasse KölnBonn | |
| 26.01.05 | Novartis Market Perform | William Blair | |
| 25.01.05 | Novartis Outperform | Goldman Sachs | |
| 25.01.05 | Novartis Halten | LB Baden-Württemberg | |
| 25.01.05 | Novartis Buy | Helvea | |
| 24.01.05 | Novartis Overweight | Prudential Securities | |
| 24.01.05 | Novartis Neutral | Sarasin Research | |
| 24.01.05 | Novartis Neutral | Sarasin Research | |
| 21.01.05 | Novartis Kaufen | Hamburger Sparkasse | |
| 21.01.05 | Novartis Kaufen | Helaba Trust | |
| 21.01.05 | Novartis Neutral | HypoVereinsbank | |
| 20.01.05 | Novartis Hold | SEB | |
| 20.01.05 | Novartis Neutral | Sarasin Research | |
| 20.01.05 | Novartis Akkumulieren | Independent Research | |
| 20.01.05 | Novartis Buy | Helvea | |
Werbung
Werbung